首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
【2h】

Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

机译:甲氧氯普胺的药代动力学静脉内和通过液相色谱法口服测定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1 A rapid and sensitive method, based on liquid chromatography, has been developed for determination of metoclopramide concentrations in plasma and urine samples. Concentrations down to 15 nmol/1 (5 ng/ml) of plasma and 100 nmol/1 (30 ng/ml) of urine could be determined with a relative standard deviation of less than or equal to 10%. The method was used to study disposition of metoclopramide in healthy volunteers following single doses intravenously and orally as aqueous solution and a slow release tablet. 2 The initial distribution after intravenous administration was very rapid. The elimination half-life postdistribution was 4.9 h. The apparent volume of distribution, Vd, was 3.0 1/kg body weight. On average 19% was excreted unchanged after intravenous administration of 5 and 10 mg (15 and 30 mumol) of drug. The rate of absorption of metoclopramide was delayed after administration of a slow release tablet and the maximum plasma concentration was about 50% lower than after a solution. The extent of bioavailability was the same following the two different formulations suggesting a first-pass elimination of 25-40%.
机译:1已经开发了一种基于液相色谱的快速灵敏的方法,用于测定血浆和尿液样品中甲氧氯普胺的浓度。血浆浓度低至15 nmol / 1(5 ng / ml)和尿液浓度可降至100 nmol / 1(30 ng / ml),相对标准偏差小于或等于10%。该方法被用于研究健康志愿者中甲氧氯普胺在以水溶液和缓释片剂的形式单次静脉内和口服给药后的处置。 2静脉给药后的初始分布非常迅速。消除后的半衰期分布为4.9 h。表观分布体积Vd为3.0 1 / kg体重。静脉内施用5和10 mg(15和30 mumol)药物后,平均19%排泄不变。服用缓释片剂后,甲氧氯普胺的吸收速率被延迟,最大血浆浓度比溶液给药后低约50%。两种不同配方的生物利用度相同,表明首过消除率为25-40%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号